Study of Association of Anti-inflammatory and Anti-rheumatic
NCT ID: NCT02448199
Last Updated: 2015-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
375 participants
INTERVENTIONAL
2015-07-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
NCT03936192
Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee
NCT02183129
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
NCT00092352
Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis
NCT00833157
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
NCT00864097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kit 1 ( ML + CG ) + P
One sachet meloxicam and glucosamine and 1 placebo tablet once a day for 12 weeks One sachet
Meloxicam and Glucosamine
Experimental
Kit 2 ( ML + P)
One tablet of meloxicam and one sachet of placebo once per day for 12 weeks
Meloxicam
Active Comparator
Kit 3 ( P+ GC)
One sachet of glucosamine and one tablet placebo once a day for 12 weeks
Glucosamine
Active Comparator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meloxicam and Glucosamine
Experimental
Meloxicam
Active Comparator
Glucosamine
Active Comparator
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 40 and 85 years
* osteoarthritis of the knee according to clinical and radiological criteria of the American College of Rheumatology
Exclusion Criteria
* Serious chronic comorbidity
* Hypersensitivity to any component of the study drugs
* body mass index\> 30 kg / m²
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eurotrials Brasil Consultores Cientificos Ltda
INDUSTRY
Zodiac Produtos Farmaceuticos S.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edio Costa, Doctor
Role: STUDY_CHAIR
CRM
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Valery F Carvalho, Biologist
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zodiac Produtos Farmacêuticos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.